Colorectal cancer is ranked third in worldwide incidence for women and fourth for men representing ͌ 9% of the world cancer or approximately 1 million new cases for 2002 (Parkin et al., 2005). Two thirds of colorectal cancers are located in the colon and one third in the rectum. At diagnosis approximately one third of all patients with colorectal cancer has lymph node positive disease, one third has lymph node-negative disease, and one third has distant metas-tases (Benson et al., 2004). The principal curative treatment for colorectal cancer is surgery. Adjuvant chemotherapy given to lymph node positive colon cancer patients has been shown to increase the survival rate (Haydon, 2003). In rectal cancer patients preoperative irradiation therapy is given to reduce local recurrences and has also been shown to improve survival (Folkesson et al., 2005). Still with these improved treatment modalities only approximately half the number of patients will survive for 5 years. For example, Swedish results for the time period 1995–1999 show a 5-years relative survival of ≈ 57% for both genders (Birgisson et al., 2005).
Tumor stage, based on histopathologi-cal examination of the resected specimen, and perioperative findings predict survival. Relative 5-year survival in Dukes' A (T1-2N0M0, Stage I) is 90–95%, Dukes' B (T3-4N0M0, Stage II) 60–80%, Dukes' C (anyTN1-2M0, Stage III) 40–60% and Dukes' D (anyTN0-2M1, Stage IV) < 5% (Staib et al., 2002). Besides distant metas-tases the most important prognostic indicator is the status of the regional lymphatic field showing presence or absence of tumor cells in regional lymph nodes. Given the importance of correctly identifying Dukes' C patients, i.e., patients with lymph node involvement who are eligible for chemotherapy, we have focused on improving the methods for detecting disseminated tumor cells in regional lymph nodes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benson, A.B., Schrag, D., Somerfield, M.R., Cohen, A.M., Figueredo, A.T., Flynn, P.J., Krzyzanowska, M.K., Maroun, J., McAllister, P., van Cutsem, E., Brouwers, M., Charette, M., and Haller, D.G. 2004. American Society of Clinical Oncology — recommendations on adjuvant chemotheraphy for stage II colon cancer. J. Clin. Oncol. 22: 3408–3419.
Birgisson, H., Talback, M., Gunnarsson, U., Påhlman, L., and Glimelius, B. 2005. Improved survival in cancer of colon and rectum in Sweden. Eur. J. Surg. Oncol. 31: 845–853.
Chomczynski, P., and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156–159.
Fahlgren, F., Hammarström, S., Danielsson, Å., and Hammarström, M.-L. 2003. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin. Exp. Immunol. 131: 90–101.
Folkesson, J., Birgisson, H., Påhlman, L., Cedermark, B., Glimelius, B., and Gunnarsson, U. 2005. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J. Clin. Oncol. 23: 5644–5650.
Haydon, A. 2003. Adjuvant chemotherapy in colon cancer: what is the evidence? Intern. Med. J. 33: 119–124.
Öberg, Å., Lindmark, G., Israelsson, A., Hammarström, S., and Hammarström, M.-L. 2004. Detection of occult tumor cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAs. Int. J. Cancer 111: 101–110.
Ohlsson, L., Hammarström, M.-L., Israelsson, A, Näslund, L., Öberg, Å., Lindmark, G., and Hammarström, S. 2006. Biomarker selection for detection of occult tumor cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR. Br. J. Cancer 95: 218–225.
Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. 2005. Global cancer statistics. CA Cancer J. Clin. 55: 74–108.
Staib, L., Link, K.H., Blatz, A., and Beger, H.B. 2002. Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients — monoinstitutional experience. World J. Surg. 26: 59–66.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media B.V.
About this chapter
Cite this chapter
Ohlsson, L., Israelsson, A., Öberg, Å., Hammarström, ML., Lindmark, G., Hammarström, S. (2009). Detection of Tumor Cells in Lymph Nodes of Colon Cancer Patients Using Real-Time Quantitative Reverse Transcription-Polymerase Chain Reaction. In: Hayat, M.A. (eds) Colorectal Cancer. Methods of Cancer Diagnosis, Therapy, and Prognosis, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9545-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4020-9545-0_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9544-3
Online ISBN: 978-1-4020-9545-0
eBook Packages: MedicineMedicine (R0)